Table 4 Clinicopathological characteristics of the patients

Gender

  Male

152 (73.8%)

  Female

54 (26.2%)

Age (year)

  <50

58 (28.2%)

  ≥50

148 (71.8%)

Weight loss (kg)

  <2.5

116 (56.3%)

  ≥2.5

90 (43.7%)

Length of tumor (cm)

  <3

88 (42.7%)

  3-5

96 (46.6%)

  >5

22 (10.7%)

Differentiation

  Well

40 (19.4%)

  Moderate

118 (57.3%)

  Poor

48 (23.3%)

Tumor location

  Upper

25 (12.1%)

  Middle

113 (54.9%)

  Lower

68 (33.0%)

T status

  T1

33 (16.0%)

  T2

110 (53.4%)

  T3

63 (30.6%)

Stage

  I

43 (20.9%)

  IIa

75 (36.4%)

  IIb

88 (42.7%)

SIRT1

  Negative

111 (53.9%)

  Positive

95 (46.1%)

VEGF-C

  Negative

99 (48.1%)

  Positive

107 (51.9%)

LVD

  Low

123 (59.7%)

  High

83 (40.3%)

LVI

  Negative

135 (65.6%)

  Positive

71 (34.5%)